Evaluation of the timing of the booster injection after a primary vaccination against hepatitis A
Authors:
- 1 February 1997
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 12 (2) , 172-175
Abstract
To evaluate the long‐term efficacy and the timing of booster injection of a lyophilized, inactivated hepatitis A vaccine (HAV), we studied the acquired anti‐hepatitis A virus titres in 45 subjects who received either two or three doses of the vaccine. With three doses ≥ 0.5 μg administered at 0, 1 and 6 months, antibody titres increased to approximately half those seen in people with a history of natural hepatitis A infection. Although the titres decreased gradually, all subjects remained anti‐HAV positive at least 5 years after the third injection. The geometric mean titre exceeded 100 mlU/mL, which approximated the highest titre obtainable by the inoculation of immune serum globulin. A prompt antibody reaction was seen with two doses administered 2 weeks apart, with the titres achieved being 5.6‐fold the peak titres obtained by the inoculation of immune serum globulin. All 33 subjects were antibody positive 18 months after the first injection, but some became seronegative by 30 months, suggesting that a third booster dose would be desirable at 18 months.Keywords
This publication has 15 references indexed in Scilit:
- Interruption of an outbreak of hepatitis A in two villages by vaccinationJournal of Medical Virology, 1994
- Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccinationJournal of Hepatology, 1994
- Long-term follow-up of antibody titers after hepatitis A vaccinationInternational Hepatology Communications, 1993
- Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overviewJournal of Hepatology, 1993
- Inactivated Hepatitis A Virus VaccinesHepatology, 1992
- Time Course of Hepatitis A Virus Antibody Titer After Active and Passive ImmunizationHepatology, 1992
- Vaccination against hepatitis A: Control 3 years after the first vaccinationVaccine, 1992
- Clinical trial of a lyophilized inactivated hepatitis A candidate vaccine in healthy adult volunteersVaccine, 1992
- Clinical study of acute hepatitis type A in patients older than fifty years.Kanzo, 1988
- Acute hepatitis A superimposed on liver cirrhosis - A report of four cases.Kanzo, 1985